SSTR2

endocrine

Somatostatin receptor type 2, a G protein-coupled receptor that mediates the inhibitory effects of somatostatin on growth hormone secretion. Primary target for cyclic peptide analogs including octreotide, lanreotide, and pasireotide.

browse 1 cards → upload → try → + watch target

anchor card · canonical reference for this target

anchor

Octreotide

FCFWKTCT · 8 aa · @peptidemodel

bioassayed pep-10808 @peptidemodel refs: 3

all cards · 1 candidates against SSTR2

# id title author status refs metric
1 pep-10981 Lanreotide: Somatuline, treatment for acromegaly and neuroendocrine tumors pe@peptidemodel
3 0
1–1 of 1

target literature · 3 curated papers

[1]
Freda, Pamela U. et al. 2005 The Journal of Clinical Endocrinology & Metabolism Long-Acting Somatostatin Analog Therapy of Acromegaly: A Meta-Analysis
cited by
1
cards
[2]
Gomes-Porras, Mariana et al. 2020 International Journal of Molecular Sciences Somatostatin Analogs in Clinical Practice: A Review
cited by
1
cards
[3]
Karimi, Anita et al. 2025 npj Precision Oncology Emerging innovations in theranostics for pancreatic neuroendocrine tumors
cited by
1
cards
recent news 4 articles

discussion · 0 threads

No discussion threads yet.